Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model.

Academic radiology

Volumn 3, Issue 4, 1996, Pages 351-360

  Hillner, B E ^a   Bear, H D ^a   Fajardo, L L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST; BREAST TUMOR; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; LABORATORY DIAGNOSIS; NEEDLE BIOPSY; PATHOLOGY; SENSITIVITY AND SPECIFICITY; STEREOTAXIC SURGERY;

BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FALSE NEGATIVE REACTIONS; FEMALE; HEALTH CARE COSTS; HUMANS; SENSITIVITY AND SPECIFICITY; STEREOTAXIC TECHNIQUES;

EID: 0030119543     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(96)80256-X     Document Type: Article

References (0)